Live
Home·IPO Tracker·Lakewood-Amedex Biotherapeutics Inc. IPO
Lakewood-Amedex Biotherapeutics Inc.
Lakewood-Amedex Biotherapeutics Inc.
Biotechnology (clinical-stage; infectious disease antimicrobials) · University Park, Florida
ExpectedNASDAQ Capital: LABT

Lakewood-Amedex Biotherapeutics Inc. IPO

Monitoring
S-1 Filed
Priced
Trading
Est. valuation
Exchange
NASDAQ Capital
Ticker: LABT
Status
Expected
IPO date
Apr 23, 2026

IPO timeline

Upcoming
S-1 filing

FireStrike is monitoring for a registration statement filing with the SEC.

Upcoming
Roadshow & pricing

Company presents to institutional investors. IPO price and share count are finalized.

Upcoming
First-day trading

Shares available on the open market.

Frequently asked questions

When is Lakewood-Amedex Biotherapeutics Inc. going public?

Lakewood-Amedex Biotherapeutics Inc. has not yet announced an IPO date or filed a registration statement with the SEC. FireStrike will update this page when official filings or announcements are made.

What is Lakewood-Amedex Biotherapeutics Inc.'s IPO valuation?

Lakewood-Amedex Biotherapeutics Inc.'s IPO valuation has not been publicly disclosed. FireStrike will update this page when a price range or offering size is announced.

What exchange will Lakewood-Amedex Biotherapeutics Inc. list on?

Lakewood-Amedex Biotherapeutics Inc. is expected to be listed on the NASDAQ Capital. The ticker symbol is LABT.

Has Lakewood-Amedex Biotherapeutics Inc. filed an S-1 with the SEC?

No. As of the most recent data, Lakewood-Amedex Biotherapeutics Inc. has not filed a Form S-1 or other registration statement with the SEC.

Sources: FireStrike proprietary index · SEC EDGAR
ShareXLinkedInEmail